|
Title
|
Published
|
Price
|
|
Biotechnology (Pharmaceuticals) Report
By: Plimsoll Publishing Ltd.
The Global Biotechnology Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial evaluation
|
more...
|
11/1/2009
|
$1,500.00
|
|
United States Biotechnology Industry - Porter’s Five Forces Strategy Analysis
By: Aruvian's R'search
The rapidly emerging biotechnology industry is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes that are relieving human suffering, improving health, and increasing the
|
more...
Search inside this report
|
11/1/2009
|
$175.00
|
|
Acorda Therapeutics, Inc. - SWOT Analysis
By: Datamonitor
Datamonitor's Acorda Therapeutics, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Acorda Therapeutics, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and
|
more...
Search inside this report
|
10/26/2009
|
$125.00
|
|
Crucell N.V. - SWOT Analysis
By: Datamonitor
Datamonitor's Crucell N.V. - SWOT Analysis company profile is the essential source for top-level company data and information. Crucell N.V. - SWOT Analysis examines the company’s key business structure and operations, history and products, and
|
more...
Search inside this report
|
10/16/2009
|
$125.00
|
|
Elan Corporation, plc - SWOT Analysis
By: Datamonitor
Datamonitor's Elan Corporation, plc - SWOT Analysis company profile is the essential source for top-level company data and information. Elan Corporation, plc - SWOT Analysis examines the company’s key business structure and operations, history and
|
more...
Search inside this report
|
10/16/2009
|
$125.00
|
|
Lonza Group Ltd - SWOT Analysis
By: Datamonitor
Datamonitor's Lonza Group Ltd - SWOT Analysis company profile is the essential source for top-level company data and information. Lonza Group Ltd - SWOT Analysis examines the company’s key business structure and operations, history and
|
more...
Search inside this report
|
10/8/2009
|
$125.00
|
|
Imclone Systems Inc.
By: SGA Lists
ImClone Systems Incorporated is a biopharmaceutical company dedicated to developing breakthrough biologic medicines in the area of oncology. The Company has utilized the many advances made in the fields of molecular biology, oncology, genomics and
|
more...
|
10/1/2009
|
$44.00
|
|
Managed Markets Account Management: Assessing the Performance of Account Executives
By: Best Practices, LLC
STUDY OVERVIEW
Today's market driven environment has made performance assessment of managed market account executives complex and critical. Best Practices, LLC has conducted this in-depth study to: identify common performance measurement practices across geographies and
|
more...
|
10/1/2009
|
$4,210.00
|
|
Genentech Incorporated
By: SGA Lists
Founded more than 30 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for significant unmet medical needs. A considerable number of the currently approved biotechnology products originated from,
|
more...
|
10/1/2009
|
$200.00
|
|
Transfection Life Science Dashboard™ Series 2
By: Percepta Associates, Inc.
The ability to transfect DNA into mammalian cells and cell lines is a critical step in the analysis of gene expression, protein structure and function and molecular interactions within the cell. The Transfection Dashboard
|
more...
Search inside this report
|
10/1/2009
|
$3,850.00
|
|
Novo Nordisk Incorporated
By: SGA Lists
Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo
|
more...
|
10/1/2009
|
$145.00
|
|
MedImmune Inc.
By: SGA Lists
MedImmune is a leading innovation-focused biotechnology company whose mission is to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people
|
more...
|
10/1/2009
|
$127.00
|
|
ImmunoGen, Inc.
By: SGA Lists
ImmunoGen, Inc. develops targeted anticancer biopharmaceuticals. The Company`s proprietary TAP technology uses tumor-targeting antibodies to deliver a potent cell-killing agent specifically to cancer cells. Five anticancer compounds are in clinical testing through ImmunoGen and the
|
more...
|
10/1/2009
|
$30.00
|
|
Biogen Idec, Inc.
By: SGA Lists
Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies. Patients
|
more...
|
10/1/2009
|
$102.00
|
|
Baxter International Inc.
By: SGA Lists
Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other conditions. The company applies
|
more...
|
10/1/2009
|
$198.00
|
|
Amgen Inc.
By: SGA Lists
Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science`s promise by bringing safe and effective medicines from lab, to
|
more...
|
10/1/2009
|
$200.00
|
|
Alkermes, Inc.
By: SGA Lists
Alkermes develops innovative medicines that fit with patients` real-world needs and behaviors. We believe that when medicines are both effective and easy to take, patients are more likely to take their prescriptions and experience better
|
more...
|
10/1/2009
|
$27.00
|
|
Acorda Therapeutics, Inc.
By: SGA Lists
SGA's Individual Business Lists are 100% staff verified and details the company’s roster of key professionals and key decision makers. In addition to the executive contacts, this report contains: Company Address (Street, City, State
|
more...
|
10/1/2009
|
$27.00
|
|
ZymoGenetics Inc.
By: SGA Lists
ZymoGenetics creates novel protein drugs with the potential to significantly help patients fight their diseases. The company is developing a diverse pipeline of potential proprietary product candidates that are moving into and through clinical development.
|
more...
|
10/1/2009
|
$37.00
|
|
XOMA Ltd.
By: SGA Lists
XOMA is a leading biopharmaceutical company in the field of therapeutic antibody discovery and development. We have a royalty interest in one approved therapeutic antibody, RAPTIVA (efalizumab), which is marketed in the United States, Europe
|
more...
|
10/1/2009
|
$32.00
|
|
ViroPharma Incorporated
By: SGA Lists
ViroPharma Incorporated is committed to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin approved for oral administration for treatment of antibiotic- associated
|
more...
|
10/1/2009
|
$32.00
|
|
Neurocrine Biosciences, Incorporated
By: SGA Lists
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, certain female and male
|
more...
|
10/1/2009
|
$44.00
|
|
InterMune Inc.
By: SGA Lists
InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has an R&D portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections.
|
more...
|
10/1/2009
|
$31.00
|
|
Gilead Sciences Inc.
By: SGA Lists
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company`s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered
|
more...
|
10/1/2009
|
$186.00
|
|
Geron Corporation
By: SGA Lists
Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-cancer drug and a cancer vaccine that target
|
more...
|
10/1/2009
|
$37.00
|
|
Title
|
Published
|
Price
|
(0 items)
